Palvella Therapeutics (PVLA) Research & Development (2016 - 2024)
Historic Research & Development for Palvella Therapeutics (PVLA) over the last 11 years, with Q4 2024 value amounting to $2.5 million.
- Palvella Therapeutics' Research & Development rose 10890.59% to $2.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $8.2 million, marking a year-over-year decrease of 730.13%. This contributed to the annual value of $8.2 million for FY2024, which is 730.13% down from last year.
- Per Palvella Therapeutics' latest filing, its Research & Development stood at $2.5 million for Q4 2024, which was up 10890.59% from $3.2 million recorded in Q3 2024.
- In the past 5 years, Palvella Therapeutics' Research & Development registered a high of $18.9 million during Q3 2021, and its lowest value of -$28.6 million during Q4 2023.
- Moreover, its 5-year median value for Research & Development was $12.4 million (2020), whereas its average is $9.2 million.
- Per our database at Business Quant, Palvella Therapeutics' Research & Development plummeted by 31340.81% in 2023 and then soared by 10890.59% in 2024.
- Quarter analysis of 5 years shows Palvella Therapeutics' Research & Development stood at $10.6 million in 2020, then soared by 44.63% to $15.4 million in 2021, then fell by 12.87% to $13.4 million in 2022, then tumbled by 313.41% to -$28.6 million in 2023, then skyrocketed by 108.91% to $2.5 million in 2024.
- Its Research & Development stands at $2.5 million for Q4 2024, versus $3.2 million for Q3 2024 and $1.4 million for Q2 2024.